Current Treatments as of March 2018

IMPORTANT: As of March 13, 2018,  anyone in B.C. living with this now-curable virus will have a choice of several treatment options – all of which are fully funded under PharmaCare, and all restrictions based on disease level have been removed.

There are many drug combinations available for treating hepatitis C in Canada which are also covered by BC Pharmacare.  Many of the older combinations involve the use of interferon which has many side effects. The list below is of the latest and most effective drugs for treating hepatitis C in Canada.

Although there are fewer side effects with the new drugs compared to those of earlier treatments (telaprevir, interferon), there can be serious side effects for people with underlying conditions, such as heart disease and advanced cirrhosis.

Some of the newer combinations may still require the addition of interferon and/or ribavirin depending on the severity of the disease.

Your physician and clinical nurses will guide you through what you need to know and what you need to do should you be accepted for treatment.

 

Genotypes 1a or 1b (GT1a/1b):

  • Harvoni:
    This drug combination is covered by BC Pharmacare
  • Zepatier (grazoprevir / elbasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Epclusa (sofosbuvir / velpatasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Sunpreva (asunaprevir) plus Daklinza (Daclatasvir) for GT1b:
    This drug combination is covered by BC Pharmacare
  • Vosevi This drug combination is covered by BC Pharmacare
  • Holkira Pak:
    This drug combination is no longer covered by BC Pharmacare
  • MAVIRET This drug combination is NOT covered by BC Pharmacare

Genotype 2:

  • Epclusa (sofosbuvir / velpatasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Sovaldi in combination with ribavirin:
    This drug combination is covered by BC Pharmacare
  • Vosevi This drug combination is covered by BC Pharmacare
  • MAVIRET This drug combination is NOT covered by BC Pharmacare

Genotype 3:

  • Daklinza plus Sovaldi:
    This drug combination is covered by BC Pharmacare
  • Epclusa (sofosbuvir / velpatasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Sovaldi in combination with ribavirin:
    This drug combination is covered by BC Pharmacare
  • Vosevi This drug combination is covered by BC Pharmacare
  • MAVIRET This drug combination is NOT covered by BC Pharmacare

Genotype 4:

  • Epclusa (sofosbuvir / velpatasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Zepatier (grazoprevir / elbasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Vosevi This drug combination is covered by BC Pharmacare
  • MAVIRET This drug combination is NOT covered by BC Pharmacare

Genotype 5:

  • Epclusa (sofosbuvir / velpatasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Vosevi This drug combination is covered by BC Pharmacare
  • MAVIRET This drug combination is NOT covered by BC Pharmacare

Genotype 6:

  • Epclusa (sofosbuvir / velpatasvir) with or without ribavirin:
    This drug combination is covered by BC Pharmacare
  • Vosevi This drug combination is covered by BC Pharmacare
  • MAVIRET This drug combination is NOT covered by BC Pharmacare

 

For more detailed information on the status of current HCV treatment in Canada

TREATMENT ACCESS MAP
Directions:
Click on the Province or Territory name.
Click on “HCV Medications”
Click on the name of the drug to get all the important information you need about the drug.

 

For information on HCV treatment applications and approvals in Canada click here: http://hepatitiseducation.med.ubc.ca/resources/english-resources/treatment-news/